药物释放系统基于复合聚烯酸纳米纤维膜,具有形状记忆效果和抗菌能力的双重功能
Le Thi Le1, Hue Thi Nguyen1, Ha Thi Thu Bui1
1Phenikaa University Nano Institute (PHENA), Phenikaa University Hanoi 12116 Vietnam thuy.nguyenthithu@phenikaa-uni.edu.vn +84924926886.
RSC advances
|August 28, 2024
概括
这项研究开发了一种智能复合纳米纤维膜,使用聚烯酸纳米纤维. 这种材料提供了可控的药物释放,形状记忆和生物医学用途的抗菌特性.
科学领域:
- 生物材料科学 生物材料科学
- 聚合物化学 聚合物化学
- 纳米技术纳米技术
背景情况:
- 开发用于生物医学应用的先进材料至关重要.
- 聚烯酸 (PCL) 纳米纤维为药物输送和组织工程提供了一个多功能平台.
- 将多个功能集成到一个材料中可以增强其治疗潜力.
研究的目的:
- 使用聚卡普罗拉克纳米纤维创建一个多功能复合膜.
- 为了结合可控药物释放,形状记忆效果和抗菌特性.
- 为了研究石墨烯氧化物,氧化纳米粒子,聚乙烯糖醇和柏柏林对膜性能的影响.
主要方法:
- 电技术被用来制造复合膜.
- 进行了形态,结晶度和热性质的表征.
- 对形状记忆恢复,药物释放动力学和抗菌活性进行了评估.
主要成果:
- 与纯PCL (22.8%) 相比,复合膜表现出增强的形状记忆恢复 (76.3%).
- 改善的湿透性导致40个小时内显著的柏柏林 (BBR) 释放 (42.7%重量%).
- 根据变形比率证明了有效的抗菌活性和可控制的BBR释放.
结论:
- 开发的复合纳米纤维膜显示了作为生物医学应用的智能材料的前景.
- 潜在的应用包括先进的伤口带和复杂的药物输送系统.
- 嵌入式组件的协同效应使得定制的材料特性能够提高治疗效果.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
137
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
137
Modified-Release Drug Delivery Systems: Classification
315
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
315
Modified-Release Drug Delivery Systems: Rate-Programmed I
172
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
172
Modified-Release Drug Delivery Systems: Stimuli-Activated
177
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
177
Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160
Oral Drug Delivery Systems: Delayed-Release Systems
222
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
222


